CytoDyn (CYDY) Current Leases (2019 - 2022)

CytoDyn (CYDY) posted Current Leases of $134000.0 for Q2 2022, down 1.47% on a QoQ basis from $136000.0 in Q1 2022, and down 23.43% year-over-year from $175000.0 in Q2 2021.

CytoDyn (CYDY) Current Leases (2019 - 2022) Analysis & Trends

CytoDyn's Current Leases history runs 4 years deep, the most recent figure standing at $134000.0 for Q2 2022.

  • Quarterly Current Leases fell 23.43% year-over-year to $134000.0 in Q2 2022, while the trailing twelve-month figure through May 2022 was $134000.0 (down 23.43% YoY) and the FY2022 annual result came in at $134000.0, down 23.43% from the prior year.
  • Current Leases was $134000.0 for Q2 2022 at CytoDyn, down from $136000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $183000.0 in Q1 2021 and bottomed at $106827.0 in Q3 2019.
  • A 4-year average of $133977.2 and a median of $126536.0 in 2020 frame the typical range for Current Leases.
  • Annual changes were most pronounced in 2021 — Current Leases jumped 53.69% — and 2022, when it decreased 25.68%.
  • CytoDyn's Current Leases stood at $106827.0 in 2019, then gained by 3.91% to $111000.0 in 2020, then soared by 34.23% to $149000.0 in 2021, then fell by 10.07% to $134000.0 in 2022.
  • Business Quant data shows CYDY's Current Leases at $134000.0 in Q2 2022, $136000.0 in Q1 2022, and $149000.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 531,233.95
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 20.58 Mn
4 NuCana 279.75 Bn 279.75 Bn - 872,589.03
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 720.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 11.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 16.61 Mn
10 CytoDyn 267.79 Mn 267.79 Mn - -

Historic Data

Download Data
DateValue
May 31, 2022 134,000.00
Feb 28, 2022 136,000.00
Nov 30, 2021 149,000.00
Aug 31, 2021 162,000.00
May 31, 2021 175,000.00
Feb 28, 2021 183,000.00
Nov 30, 2020 111,000.00
Aug 31, 2020 110,000.00
May 31, 2020 115,000.00
Feb 29, 2020 119,072.00
Nov 30, 2019 106,827.00
Aug 31, 2019 106,827.00